Torres RM - Search Results

1

BRAF Modulates Lipid Use and Accumulation.

Turner JA, Paton EL, Van Gulick R, Stefanoni D, Cendali F, Reisz J, Tobin RP, McCarter M, D'Alessandro A, Torres RM, Robinson WA, Couts KL, Schlaepfer IR. Turner JA, et al. Among authors: torres rm. Cancers (Basel). 2022 Apr 23;14(9):2110. doi: 10.3390/cancers14092110. Cancers (Basel). 2022. PMID: 35565240 Free PMC article.

2

Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies.

Pujanauski LM, Janoff EN, McCarter MD, Pelanda R, Torres RM. Pujanauski LM, et al. Among authors: torres rm. Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1422-7. doi: 10.1073/pnas.1213713110. Epub 2013 Jan 3. Proc Natl Acad Sci U S A. 2013. PMID: 23288906 Free PMC article.

3

Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation.

Lang J, Kelly M, Freed BM, McCarter MD, Kedl RM, Torres RM, Pelanda R. Lang J, et al. Among authors: torres rm. J Immunol. 2013 Mar 1;190(5):2090-101. doi: 10.4049/jimmunol.1202810. Epub 2013 Jan 18. J Immunol. 2013. PMID: 23335750 Free PMC article.

4

Regulation of Tumor Immunity by Lysophosphatidic Acid.

Lee SC, Dacheux MA, Norman DD, Balázs L, Torres RM, Augelli-Szafran CE, Tigyi GJ. Lee SC, et al. Among authors: torres rm. Cancers (Basel). 2020 May 10;12(5):1202. doi: 10.3390/cancers12051202. Cancers (Basel). 2020. PMID: 32397679 Free PMC article. Review.

5

Regulation of CD8 T-cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid.

Torres RM, Turner JA, D'Antonio M, Pelanda R, Kremer KN. Torres RM, et al. Immunol Rev. 2023 Aug;317(1):203-222. doi: 10.1111/imr.13208. Epub 2023 Apr 25. Immunol Rev. 2023. PMID: 37096808 Free PMC article. Review.

6

Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity.

Turner JA, Fredrickson MA, D'Antonio M, Katsnelson E, MacBeth M, Van Gulick R, Chimed TS, McCarter M, D'Alessandro A, Robinson WA, Couts KL, Pelanda R, Klarquist J, Tobin RP, Torres RM. Turner JA, et al. Among authors: torres rm. Nat Commun. 2023 Jun 3;14(1):3214. doi: 10.1038/s41467-023-38933-4. Nat Commun. 2023. PMID: 37270644 Free PMC article.

7

Autoreactive Antibodies Associated with Castleman Disease Triad.

Turner JA, Hakimi A, Lee H, Schowinsky JT, Sippel JM, Siegele BJ, Torres RM, Robinson WA. Turner JA, et al. Among authors: torres rm. Case Reports Immunol. 2024 Mar 6;2024:9382107. doi: 10.1155/2024/9382107. eCollection 2024. Case Reports Immunol. 2024. PMID: 38482465 Free PMC article.

8

Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion via Mechanisms Similar and Distinct From CTLA-4 and PD-1.

Mathew D, Torres RM. Mathew D, et al. Among authors: torres rm. Front Immunol. 2021 Jan 27;11:531910. doi: 10.3389/fimmu.2020.531910. eCollection 2020. Front Immunol. 2021. PMID: 33584637 Free PMC article. Review.

9

Lipid mediators in the regulation of innate and adaptive immunity.

Torres RM, Cyster J. Torres RM, et al. Immunol Rev. 2023 Aug;317(1):4-7. doi: 10.1111/imr.13228. Epub 2023 May 26. Immunol Rev. 2023. PMID: 37243330 No abstract available.

10

LPA₅ Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling.

Mathew D, Kremer KN, Strauch P, Tigyi G, Pelanda R, Torres RM. Mathew D, et al. Among authors: torres rm. Front Immunol. 2019 May 28;10:1159. doi: 10.3389/fimmu.2019.01159. eCollection 2019. Front Immunol. 2019. PMID: 31231367 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters